Clinical Research Objectives

LEARN

How does CardioSecur perform in different indications?

What is the feedback from various stakeholders?

What are potential use cases?

ENGAGE

Engage with the leading European cardiovascular research institutes

Engage with patient across Europe to explore the potential of (big) data

Generate content for PR (online and offline)

INFORM

Generate evidence to show the value of CardioSecur

Inform decision making in health care on all levels

Patient – individual physicians – health insurances

REDUCE Study

Design

Single centre

Main Endpoints

  • Detection of cardiac events

Population

  • Patients with syn = 148 episodes of inflation

Status & Results

  • Finished and published*

* Van Langenhove G. 2014.

The results of the ‘Revealing timely ECG changes decreases the likelihood of Undesirable Cardiac Events-Trial’ (REDUCE-Study) were presented at the European Society of Cardiology annual meeting in Barcelona in 2014 and at other international conferences.

REDUCE POSTER

Validation Study

Design

Single center, controlled study

Main Endpoints

  • Validation of CardioSecur vs. standard ECG

Population

  • Patients in the cath lab
  • n = 148 episodes of inflation

Status & Results

  • Finished and published*

4_Electrodes_-_European_Cardiology_2012_Bonaventura_et_al4_Electrodes_-_European_Cardiology_2012_Bonaventura_et_al

* Bonaventura K et al. 2012. European Cardiology, 2012;8(3):179

mHealth Review

Design

Literature review

Main Endpoints

  • Overview of evidence for mHealth technologies in cardiology

Status & Results

  • Evidence is scarce
  • More high-quality evidence needed

* Van Langenhove G. Deeg M. 2015.